Literature DB >> 12858117

Is miscarriage a coagulopathy?

Raj Rai1.   

Abstract

PURPOSE OF REVIEW: Pregnancy is a hypercoaguable state. The hypothesis has been developed that many cases of recurrent miscarriage and of later pregnancy complications are caused by a defective maternal haemostatic response leading to thrombosis of the uteroplacental vasculature and subsequent fetal loss. The evidence upon which this hypothesis is based is reviewed. RECENT
FINDINGS: The majority of studies report an increased prevalence of genetic thrombophilic mutations in the female partner of couples with recurrent miscarriage. It is important to note, however, that this is not a uniform finding. A sub-group of women with recurrent miscarriage has been demonstrated to be in a prothrombotic state before pregnancy, and that women in such a state are at an increased risk of miscarriage in future untreated pregnancies. Furthermore, the long-term health implications of this hypercoaguability have been highlighted in a large retrospective study reporting an increased risk of ischaemic heart disease among women with a history of pregnancy loss.
SUMMARY: Although recurrent miscarriage is a heterogeneous condition and no single abnormality will account for all cases of pregnancy loss, the relationship between abnormalities in the haemostatic pathways and pregnancy outcome is increasingly recognized. The challenges we face are how to discriminate between women with a thrombophilic defect who are destined to miscarry from those whose pregnancy will be successful, the pathology of pregnancy loss associated with thrombophilic defects, the role of the fetal genotype in determining pregnancy outcome, and the management of women with thrombophilic defects both during and beyond their reproductive years.

Entities:  

Mesh:

Year:  2003        PMID: 12858117     DOI: 10.1097/00001703-200306000-00010

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  5 in total

Review 1.  Recurrent miscarriage, antiphospholipid antibodies and the risk of thromboembolic disease.

Authors:  M Ángeles Martínez-Zamora; Ricard Cervera; Juan Balasch
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

2.  Association of the R67X and W303X non-sense polymorphisms in the protein Z-dependent protease inhibitor gene with idiopathic recurrent miscarriage.

Authors:  F S AlShaikh; R R Finan; A W Almawi; F E Mustafa; W Y Almawi
Journal:  Mol Hum Reprod       Date:  2011-10-27       Impact factor: 4.025

3.  Differences in thrombotic risk factors in black and white women with adverse pregnancy outcome.

Authors:  Claire S Philipp; Ambarina S Faiz; Michele G Beckman; Althea Grant; Paula L Bockenstedt; John A Heit; Andra H James; Roshni Kulkarni; Marilyn J Manco-Johnson; Stephan Moll; Thomas L Ortel
Journal:  Thromb Res       Date:  2013-11-01       Impact factor: 3.944

4.  Tocolysis and the risk of nonreassuring fetal status among pregnant women in labor: Findings from a population-based retrospective cohort study.

Authors:  I-Te Wang; Meng-Ting Tsai; Steven R Erickson; Chung-Hsuen Wu
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

5.  Elevated procoagulant endothelial and tissue factor expressing microparticles in women with recurrent pregnancy loss.

Authors:  Rucha Patil; Kanjaksha Ghosh; Purnima Satoskar; Shrimati Shetty
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.